COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 2896: Articles 28951-28960  | Next

COVID-19 Epidemic in Algeria: Assessment of the implemented preventive strategy
HAMIDOUCHE, M.
10.1101/2020.04.21.20074443 — Posted: 2020-04-26
Taking Account of Asymptomatic Infections in Modeling the Transmission Potential of the COVID-19 Outbreak on the Diamond Princess Cruise Ship
Huang, L.-S., Li, L., Dunn, L., He, M.
10.1101/2020.04.22.20074286 — Posted: 2020-04-26
The proportion testing positive for SARS-COV-2 among the tested population in the U.S.: Benefits of the positive test ratio under scaled testing scenarios
Ng, G., Wang, C.
10.1101/2020.04.21.20074070 — Posted: 2020-04-26
A statistical forecast of LOW mortality and morbidity due to COVID-19, in ARGENTINA and other Southern Hemisphere countries.
barbero, c. a.
10.1101/2020.04.20.20072488 — Posted: 2020-04-26
Understanding the asymmetric spread and case fatality rate (CFR) for COVID-19 among countries
Iype, E., Gulati, S.
10.1101/2020.04.21.20073791 — Posted: 2020-04-26 Discussion: Onsite
Forecasting the impact of the first wave of the COVID-19 pandemic on hospital demand and deaths for the USA and European Economic Area countries
IHME COVID-19 health service utilization forecasting team, , Murray, C. J.
10.1101/2020.04.21.20074732 — Posted: 2020-04-26 Discussion: Onsite
Research on CNN-based Models Optimized by Genetic Algorithm and Application in the Diagnosis of Pneumonia and COVID-19
Zeng, Z., Wang, B., Zhao, Z.
10.1101/2020.04.21.20072637 — Posted: 2020-04-26
Analysis of Effectiveness of Quarantine Measures in Controlling COVID-19
Kaushik, G., Kaushik, S., Mantri, S., Kalbande, D., Chaudhari, B. N.
10.1101/2020.04.21.20074245 — Posted: 2020-04-26
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19
Schmith, V. D., Zhou, J., Lohmer, L. R.
10.1101/2020.04.21.20073262 — Posted: 2020-04-26 Discussion: Onsite
Forecast and interpretation of daily affected people during 21 days lockdown due to COVID 19 pandemic in India
Bhattacharyya, A., Bhowmik, D., Mukherjee, J.
10.1101/2020.04.22.20075572 — Posted: 2020-04-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).